Clinical Trials Directory

Trials / Unknown

UnknownNCT05504447

To Evaluate the Efficacy and Safety of "Rongyang Zhengyifang" Tea Bag With COVID-19 Variant Virus

To Evaluate the Efficacy and Safety of "Rongyang Zhengyifang" Tea Bag in Mildly Diagnosed Patients With COVID-19 Variant Virus

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
92 (estimated)
Sponsor
Taipei Veterans General Hospital, Taiwan · Other Government
Sex
All
Age
20 Years
Healthy volunteers
Accepted

Summary

The strategy of our study is to use traditional Chinese medicine tea to regulate physical fitness and strength can be enhanced to help patients with mildly diagnosed COVID-19 variant virus to achieve self-recovery ability and avoid the development of moderate and severe symptoms.

Detailed description

According to the "Interim Guidelines for the Clinical Treatment of Novel Coronavirus SARS-CoV-2 Infection" published by the CDC of the Ministry of Health and Welfare on June 23, 2021, it can be classified into mild, moderate, severe and extremely severe according to the classification of its related clinical manifestations. Current clinical studies have found that COVID-19 primarily attacks the bronchioles and alveoli of the lower respiratory tract. In severe cases, it may induce an inflammatory response, leading to pulmonary airway and alveolar damage, and even pulmonary fibrosis. The strategy of our study is to use traditional Chinese medicine tea to regulate physical fitness and strength can be enhanced to help patients with mildly diagnosed COVID-19 variant virus to achieve self-recovery ability and avoid the development of moderate and severe symptoms.It may reduce the expenditure of health insurance and medical expenses, and more importantly, if it can be administered timely to block the progression of the disease when mild-to-moderate symptoms occur, it can also reduce the burden of hospital medical care.

Conditions

Interventions

TypeNameDescription
OTHERRong-Yang Zhengyifang" tea bagOne tea bag is 4 grams, 3 bags per day, for a total of 7 days
OTHERplacebo tea bagOne tea bag is 4 grams, 3 bags per day, for a total of 7 days

Timeline

Start date
2022-08-15
Primary completion
2023-02-28
Completion
2024-06-01
First posted
2022-08-17
Last updated
2023-08-03

Locations

1 site across 1 country: Taiwan

Source: ClinicalTrials.gov record NCT05504447. Inclusion in this directory is not an endorsement.